Waterfront Capital Partners’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-860,000
Closed -$12M 50
2023
Q3
$12M Buy
+860,000
New +$11M 1.18% 28
2022
Q4
Sell
-1,470,100
Closed -$19.3M 54
2022
Q3
$19.3M Buy
1,470,100
+321,585
+28% +$4.75M 1.44% 23
2022
Q2
$16M Sell
1,148,515
-377,490
-25% -$5.05M 1.08% 26
2022
Q1
$22.7M Buy
+1,526,005
New +$20.9M 1.42% 24

Other funds holding SBRA

Waterfront Capital Partners's SBRA Position: Q4 2023 in Review

Waterfront Capital Partners sold out of Sabra Healthcare REIT (SBRA) in Q4 2023, closing a stake of 860,000 shares — an estimated $12M sold.

Waterfront Capital Partners first reported a position in SBRA in Q1 2022 and held it in 4 quarters. The position peaked at $22.7M in Q1 2022. 359 funds tracked by Wall St. Rank hold SBRA as of Q4 2023.

  • Waterfront Capital Partners reported no remaining Sabra Healthcare REIT position as of Q4 2023 after selling out during the quarter.
  • Waterfront Capital Partners sold 860,000 Sabra Healthcare REIT shares in Q4 2023, an estimated $12M.
  • Waterfront Capital Partners first reported a position in Sabra Healthcare REIT in Q1 2022 and held it in 4 quarters.
  • Waterfront Capital Partners's Sabra Healthcare REIT position peaked at $22.7M in Q1 2022.
  • 359 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2023.

Based on Waterfront Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.